322 related articles for article (PubMed ID: 1632664)
1. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome.
Jedryka-Goral A; Jagiello P; D'Cruz DP; Maldykowa H; Khamashta MA; Hughes GR; Swana GT; Luft S
Ann Rheum Dis; 1992 Jul; 51(7):889-91. PubMed ID: 1632664
[TBL] [Abstract][Full Text] [Related]
2. Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome.
Pennec YL; Magadur G; Jouquan J; Youinou P
Clin Exp Rheumatol; 1991; 9(2):165-7. PubMed ID: 2060162
[TBL] [Abstract][Full Text] [Related]
3. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
4. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjögren's syndrome.
Iwasaki K; Okawa-Takatsuji M; Aotsuka S; Ono T
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):346-54. PubMed ID: 14752936
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in the sicca syndrome (primary Sjögren's syndrome).
Elkon KB; Gharavi AE; Hughes GR; Moutsoupoulos HM
Ann Rheum Dis; 1984 Apr; 43(2):243-5. PubMed ID: 6712296
[TBL] [Abstract][Full Text] [Related]
8. Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome.
Hietaharju A; Korpela M; Ilonen J; Frey H
Ann Rheum Dis; 1992 Apr; 51(4):506-9. PubMed ID: 1586250
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome and polymyositis or dermatomyositis.
Ringel SP; Forstot JZ; Tan EM; Wehling C; Griggs RC; Butcher D
Arch Neurol; 1982 Mar; 39(3):157-63. PubMed ID: 7039564
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
11. Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome.
Halse AK; Marthinussen MC; Wahren-Herlenius M; Jonsson R
Scand J Rheumatol; 2000; 29(1):13-9. PubMed ID: 10722253
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.
Asherson RA; Fei HM; Staub HL; Khamashta MA; Hughes GR; Fox RI
Ann Rheum Dis; 1992 Apr; 51(4):495-8. PubMed ID: 1586247
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
14. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
16. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome.
Aydemir YG; Kocakusak A
Clinics (Sao Paulo); 2019; 74():e631. PubMed ID: 31241661
[TBL] [Abstract][Full Text] [Related]
18. Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations.
Müller K; Oxholm P; Mier-Madsen M; Wiik A
Scand J Rheumatol; 1989; 18(1):29-31. PubMed ID: 2784865
[TBL] [Abstract][Full Text] [Related]
19. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome.
Maran R; Dueymes M; Pennec YL; Casburn-Budd R; Shoenfeld Y; Youinou P
J Autoimmun; 1993 Jun; 6(3):379-87. PubMed ID: 8397718
[TBL] [Abstract][Full Text] [Related]
20. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
ter Borg EJ; Kelder JC
Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
